Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Cystine and homocystine, urine, qualitative

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 82615 refers to a laboratory test that qualitatively assesses the presence of two specific amino acids, cystine and homocystine, in urine. Cystine is formed from the breakdown of the amino acids lysine, ornithine, and arginine. Under normal circumstances, cystine is reabsorbed by the kidneys; however, when this process is impaired, cystine can accumulate and precipitate in the urine, leading to the formation of kidney stones. This condition is known as cystinuria, which is typically attributed to an inherited genetic disorder affecting the renal tubular reabsorption of cystine. On the other hand, homocystinuria is associated with metabolic disorders related to the amino acid methionine, which may arise from deficiencies in specific enzymes, such as cystathionine beta synthase, or from vitamin B deficiencies, including B2, B6, B9, and B12. Elevated levels of homocystine can manifest in a variety of multisystemic symptoms, which may include disorders affecting connective tissues, muscles, the central nervous system, and cardiovascular health. To perform this test, a urine sample is collected, either through a voided specimen or catheterization, and is subsequently analyzed for the presence of cystine and homocystine using spectrometry techniques.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The qualitative urine test for cystine and homocystine is indicated for the following conditions:

  • Cystinuria This condition is characterized by the presence of cystine in the urine, which can lead to the formation of kidney stones due to the inability of the kidneys to reabsorb cystine effectively.
  • Homocystinuria This metabolic disorder results from defects in the metabolism of methionine, leading to elevated levels of homocystine in the urine, which can cause various multisystemic symptoms.
  • Inherited metabolic disorders These may include conditions related to deficiencies in enzymes responsible for amino acid metabolism, particularly those affecting cystathionine beta synthase.
  • Vitamin B deficiencies Deficiencies in vitamins B2, B6, B9, and B12 can contribute to elevated homocystine levels, warranting testing to assess amino acid metabolism.

2. Procedure

The procedure for testing urine for cystine and homocystine involves several key steps:

  • Sample Collection A urine sample is obtained, which can be done through a voided specimen or catheterization. The method of collection may depend on the patient's condition and the clinical setting.
  • Sample Preparation Once the urine sample is collected, it is prepared for analysis. This may involve centrifugation or other techniques to ensure that the sample is suitable for testing.
  • Testing Methodology The prepared urine sample is then subjected to spectrometry, a technique that allows for the qualitative analysis of cystine and homocystine levels. This method provides precise measurements of the amino acids present in the urine.
  • Result Interpretation After the analysis is complete, the results are interpreted by laboratory professionals. The presence of cystine and homocystine is evaluated to determine if they are within normal ranges or indicative of a disorder.

3. Post-Procedure

After the urine sample has been tested for cystine and homocystine, the results will be documented and communicated to the healthcare provider. Depending on the findings, further diagnostic testing or clinical evaluation may be necessary to confirm a diagnosis or to assess the need for treatment. Patients may be advised on dietary modifications or other management strategies if elevated levels of cystine or homocystine are detected. Follow-up appointments may be scheduled to monitor the patient's condition and response to any interventions.

Short Descr TEST FOR URINE CYSTINES
Medium Descr CSTINE&HOMOCSTINE URINE QUALITATIVE
Long Descr Cystine and homocystine, urine, qualitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GW Service not related to the hospice patient's terminal condition
Q3 Live kidney donor surgery and related services
Date
Action
Notes
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"